Gastroenterology
Volume 139, Issue 2 , Pages 430-438 , August 2010

Determinants of Changes in Linear Growth and Body Composition in Incident Pediatric Crohn's Disease

  • Meena Thayu

      Affiliations

    • Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Corresponding Author InformationReprint requests Address requests for reprints to: Meena Thayu, MD, MSCE, Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, 34th and Civic Center Boulevard, Philadelphia, PA 19104. fax: (215) 590-0604
    • ,
  • Lee A. Denson

      Affiliations

    • Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
    • ,
  • Justine Shults

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Babette S. Zemel

      Affiliations

    • Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    • ,
  • Jon M. Burnham

      Affiliations

    • Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Robert N. Baldassano

      Affiliations

    • Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    • ,
  • Krista M. Howard

      Affiliations

    • Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    • ,
  • Anne Ryan

      Affiliations

    • Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
    • ,
  • Mary B. Leonard

      Affiliations

    • Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Received 26 January 2010 ,Accepted 21 April 2010.

References 

  1. Roubenoff R, Kehayias JJ. The meaning and measurement of lean body mass. Nutr Rev. 1991;49:163–175
  2. Schonau E, Werhahn E, Schiedermaier U, et al. Influence of muscle strength on bone strength during childhood and adolescence. Horm Res. 1996;45(Suppl 1):63–66
  3. Boot AM, Bouquet J, Krenning EP, et al. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998;42:188–194
  4. Capristo E, Addolorato G, Mingrone G, et al. Effect of disease localization on the anthropometric and metabolic features of Crohn's disease. Am J Gastroenterol. 1998;93:2411–2419
  5. Capristo E, Mingrone G, Addolorato G, et al. Metabolic features of inflammatory bowel disease in a remission phase of the disease activity. J Intern Med. 1998;243:339–347
  6. Mingrone G, Benedetti G, Capristo E, et al. Twenty-four-hour energy balance in Crohn disease patients: metabolic implications of steroid treatment. Am J Clin Nutr. 1998;67:118–123
  7. Haderslev KV, Jeppesen PB, Sorensen HA, et al. Body composition measured by dual-energy x-ray absorptiometry in patients who have undergone small-intestinal resection. Am J Clin Nutr. 2003;78:78–83
  8. Azcue M, Rashid M, Griffiths A, et al. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut. 1997;41:203–208
  9. Jahnsen J, Falch JA, Mowinckel P, et al. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2003;98:1556–1562
  10. Geerling BJ, Lichtenbelt WD, Stockbrugger RW, et al. Gender specific alterations of body composition in patients with inflammatory bowel disease compared with controls. Eur J Clin Nutr. 1999;53:479–485
  11. Schneeweiss B, Lochs H, Zauner C, et al. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr. 1999;129:844–848
  12. Rocha R, Santana GO, Almeida N, et al. Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase. Br J Nutr. 2009;101:676–679
  13. Lee N, Radford-Smith GL, Forwood M, et al. Body composition and muscle strength as predictors of bone mineral density in Crohn's disease. J Bone Miner Metab. 2009;27:456–463
  14. Schneider SM, Al-Jaouni R, Filippi J, et al. Sarcopenia is prevalent in patients with Crohn's disease in clinical remission. Inflamm Bowel Dis. 2008;14:1562–1568
  15. Burnham JM, Shults J, Semeao E, et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res. 2004;19:1961–1968
  16. Burnham JM, Shults J, Semeao E, et al. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr. 2005;82:413–420
  17. Roubenoff R, Roubenoff RA, Ward LM, et al. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis (Possible association with tumor necrosis factor). J Rheumatol. 1992;19:1505–1510
  18. Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxford). 2004;43:1219–1223
  19. Thayu M, Shults J, Burnham JM, et al. Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease. Inflamm Bowel Dis. 2007;13:1121–1128
  20. Sylvester FA, Leopold S, Lincoln M, et al. A two-year longitudinal study of persistent lean tissue deficits in children with Crohn's disease. Clin Gastroenterol Hepatol. 2009;7:452–455
  21. Dubner SE, Shults J, Baldassano RN, et al. Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology. 2009;136:123–130
  22. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753
  23. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439–447
  24. Morris NN, Udry JR. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc. 1980;271–280
  25. Tanner JM. Growth at Adolescence. Hobokon, NJ: Blackwell Scientific Publication; 1962;
  26. Foster BJ, Shults J, Zemel BS, et al. Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids. Am J Clin Nutr. 2004;80:1334–1341
  27. Ellis KJ, Shypailo RJ, Abrams SA, et al. The reference child and adolescent models of body composition (A contemporary comparison). Ann N Y Acad Sci. 2000;904:374–382
  28. Ellis KJ. Body composition of a young, multiethnic, male population. Am J Clin Nutr. 1997;66:1323–1331
  29. Goulding A, Taylor RW, Gold E, et al. Regional body fat distribution in relation to pubertal stage: a dual-energy x-ray absorptiometry study of New Zealand girls and young women. Am J Clin Nutr. 1996;64:546–551
  30. Ogle GD, Allen JR, Humphries IR, et al. Body-composition assessment by dual-energy x-ray absorptiometry in subjects aged 4-26 y. Am J Clin Nutr. 1995;61:746–753
  31. Lloyd T, Chinchilli VM, Eggli DF, et al. Body composition development of adolescent white females: the Penn State Young Women's Health Study. Arch Pediatr Adolesc Med. 1998;152:998–1002
  32. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109:45–60
  33. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr. 1990;44:45–60
  34. Shults J, Ratcliffe SJ, Leonard MB. Improved generalized estimating equation analysis via xtqls for implementation of quali-least squares in Stata. STATA J. 2007;7:147–166
  35. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:255–281vii
  36. Pfefferkorn M, Burke G, Griffiths A, et al. Growth abnormalities persist in newly diagnosed children with Crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr. 2009;48:168–174
  37. Walters TD, Gilman AR, Griffiths AM. Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease. Inflamm Bowel Dis. 2007;13:424–430
  38. Thayu M, Leonard MB, Hyams JS, et al. Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study. Clin Gastroenterol Hepatol. 2008;6:1378–1384
  39. Denson L, Held M, Arnold D, et al. Interleukin 6 inhibits growth hormone signaling via induction of cis and socs-3. Gastroenterology. 2002;122:A42;362
  40. Sawczenko A, Azooz O, Paraszczuk J, et al. Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the −174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci U S A. 2005;102:13260–13265
  41. Langen RC, Schols AM, Kelders MC, et al. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J. 2001;15:1169–1180
  42. Langen RC, Schols AM, Kelders MC, et al. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol. 2002;283:C714–C721
  43. Stewart CE, Newcomb PV, Holly JM. Multifaceted roles of TNF-alpha in myoblast destruction: a multitude of signal transduction pathways. J Cell Physiol. 2004;198:237–247
  44. Pasternak BA, D'Mello S, Jurickova II, et al. Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis. Inflamm Bowel Dis. 2010;16:856–869
  45. Ohlsson C, Mohan S, Sjogren K, et al. The role of liver-derived insulin-like growth factor-I. Endocr Rev. 2009;30:494–535
  46. Klover P, Hennighausen L. Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle: a role for autocrine/paracrine insulin-like growth factor I. Endocrinology. 2007;148:1489–1497
  47. Lelbach A, Scharf JG, Ramadori G. Regulation of insulin-like growth factor-I and of insulin-like growth factor binding protein-1, -3 and -4 in cocultures of rat hepatocytes and Kupffer cells by interleukin-6. J Hepatol. 2001;35:558–567
  48. Alele J, Jiang J, Goldsmith JF, et al. Blockade of growth hormone receptor shedding by a metalloprotease inhibitor. Endocrinology. 1998;139:1927–1935
  49. Fisker S, Hansen B, Fuglsang J, et al. Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein. Eur J Endocrinol. 2004;150:773–777
  50. Wang X, Jiang J, Warram J, et al. Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity. Mol Endocrinol. 2008;22:1427–1437

 Conflicts of interest The authors disclose no conflicts.

 Funding National Institutes of Health R01DK60030, K23 DK082012, K24 DK076808, and R01 DK068164; North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Crohn's and Colitis Foundation of America, and The Children's Hospital of Philadelphia Clinical Translational Research Center UL1 RR024134.

PII: S0016-5085(10)00617-7

doi: 10.1053/j.gastro.2010.04.044

Gastroenterology
Volume 139, Issue 2 , Pages 430-438 , August 2010

Article Tools

* Image Usage & Resolution